Biological and clinical response to desmopressin (DDAVP) in a retrospective cohort study of children with low von Willebrand factor levels and bleeding history

von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)¹

2008 • 917 citations

1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE

1977 • 597 citations

A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM‐1 VWD)

2006 • 510 citations

Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive Drugs

1975 • 400 citations

A Method for Assaying von Willebrand Factor (Ristocetin Cofactor)

1975 • 288 citations

Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD

2008 • 198 citations

Hyponatremia and seizures in young children given ddavp

1989 • 160 citations

Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.

1974 • 131 citations

Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire

2010 • 125 citations

von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.

2000 • 120 citations

Adverse events during use of intranasal desmopressin acetate for haemophilia A and von Willebrand disease: a case report and review of 40 patients

2000 • 72 citations

von Willebrand Disease

2008 • 57 citations

Desmopressin (DDAVP) Responsiveness in Children With von Willebrand Disease

2003 • 57 citations

Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders

2000 • 48 citations

Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations

2008 • 45 citations

Plasma-derived biological medicines used to promote haemostasis

2008 • 42 citations

DDAVP IS NOT A PANACEA FOR CHILDREN WITH BLEEDING DISORDERS

2000 • 40 citations

PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2

2008 • 39 citations

Severe Hyponatraemia Secondary to Desmopressin Therapy in von Willebrand's Disease

2000 • 37 citations

Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease

2002 • 29 citations

Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's disease.

2001 • 29 citations

Type 1 von Willebrand disease: application of emerging data to clinical practice

2008 • 27 citations

Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders

2008 • 21 citations

von Willebrand disease update: diagnostic and treatment dilemmas

2008 • 20 citations

Major haemorrhage related to surgery in patients with type 1 and possible type 1 von Willebrand disease

2008 • 17 citations

The Application of the Biotin/Avidin System to the von Willebrand Factor Antigen Immunoassay

1988 • 15 citations

Applying diagnostic criteria for type 1 von Willebrand disease to a pediatric population

2008 • 13 citations

Intranasal desmopressin (Octim^TM): a safe and efficacious treatment option for children with bleeding disorders

2007 • 7 citations

Major haemorrhage related to surgery in patients with type 1 and possible type 1 von Willebrand disease

2008 • 3 citations

Cited By (0)

Loading...